San Jose, CA, United States of America

Andrew Sparks

USPTO Granted Patents = 21 

 

 

Average Co-Inventor Count = 4.1

ph-index = 7

Forward Citations = 185(Granted Patents)


Location History:

  • Los Gatos, CA (US) (2011 - 2018)
  • San Jose, CA (US) (2014 - 2022)
  • Emerald Hills, CA (US) (2022)

Company Filing History:


Years Active: 2011-2025

where 'Filed Patents' based on already Granted Patents

21 patents (USPTO):

Title: **Andrew Sparks: Innovator in Fetal Genomic Analysis**

Introduction

Andrew Sparks, an accomplished inventor based in San Jose, California, has made significant contributions to the field of fetal genomic analysis. With 16 patents to his name, Sparks stands out as a pioneer in developing non-invasive techniques that enhance the evaluation of fetal health.

Latest Patents

Among Andrew Sparks' most notable inventions is the patent titled "Risk calculation for evaluation of fetal aneuploidy." This innovative process focuses on determining accurate risk probabilities for fetal aneuploidies through non-invasive evaluation of genomic variations. The method utilizes chromosome-selective sequencing and analyzes non-host fraction data from maternal samples, showcasing a groundbreaking approach to prenatal diagnostics. Additionally, his invention of "Assay systems for genetic analysis" provides advanced assays and methods for detecting chromosomal abnormalities and assessing the status of single loci associated with various genetic traits, utilizing nucleic acids from both maternal and fetal sources.

Career Highlights

Sparks has worked with prominent companies in the diagnostics field, including Ariosa Diagnostics, Inc. and Ariosa Diagnosis, Inc. His experience in these organizations has contributed to his expertise in genetic analysis and innovation within prenatal care.

Collaborations

Throughout his career, Andrew has collaborated with distinguished professionals, including Arnold Oliphant and Ken Song. Their partnership has likely played a pivotal role in the development of his innovative ideas and inventions.

Conclusion

Andrew Sparks continues to be a vital figure in the realm of fetal genomic analysis, with his inventions paving the way for more accurate and non-invasive prenatal testing methods. His ongoing contributions are expected to have lasting effects on the industry and enhance the health outcomes for expectant families.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…